Abstract:

In April of 2012, At Ease USA launched a clinical trial of a promising new therapeutic intervention at Creighton University. The therapy called “Attention Bias Modification Treatment,” or ABMT, was developed by Dr. Yair Bar-Haim, Professor of Psychology and Neuroscience, and Head of the School of Psychological Sciences at Tel Aviv University, who was in Omaha for the launch of this research. In this new clinical trial, lead investigator Dr. Amy Badura Brack, Department of Psychology at Creighton University, examined the therapeutic impact of ABMT in soldiers who suffer from post-traumatic stress disorder (PTSD). The Creighton University study is the first trial in the United States, and one of only two trials in the world, testing the effectiveness of ABMT for PTSD.

Two years later, the study, titled “Effect of Attention Training on Attention Bias Variability and PTSD Symptoms: Randomized Controlled Trials in Israeli and U.S. Combat Veterans” has been published by The American Journal of Psychiatry.

 Image courtesy of Huffington Post, August 4, 2015

show the full article

Related Clinical Trials

  • Availability : Accepting New Patients
  • Women's Center for Advancement
  • 222 South 29th Street, Omaha, NE, United States
  • Please contact Dr. Amy Badura Brack for information related to participation.

In 2011, Scott Anderson (AEU Founder) read an article in the Economist related to Attention Bias Modification Treatment (ABMT). This treatment was being studied by Dr. Yair Bar-Haim at Tel Aviv University in Israel. A year later, AEU teamed up with Dr. Amy Badura Brack at Creighton, Dr. Tony Wilson

Progress

At Ease USA Partners with the Women’s Center for Advancement

Approximately 71% of female military personnel develop PTSD due to sexual assault within the ranks. To address this issue, AEU has partnered with the WCA’s Healing Warriors program to provide